Article
The role of epoxide hydrolase Y113H gene variant in pancreatic diseases.
Pancreas - 1 May 2009
Ockenga Johann, Strunck Sebastian, Post Cora, Schulz Hans-Ulrich, Halangk Juliane, Pfützer Roland H, Löhr Matthias, Oettle Helmut, Kage Andreas, Rosendahl Jonas, Keim Volker, Drenth Joost P H, Jansen Jan B M J, Lochs Herbert, Witt Heiko
Abstract excerpt
OBJECTIVES: Chronic pancreatitis (CP) and pancreatic adenocarcinoma (pCA) are associated with risk factors such as alcohol intake and tobacco smoking. Microsomal epoxide hydrolase (EPHX1) is a phase II detoxifying enzyme capable of tobacco-borne toxicant inactivation. We studied the role of the EPHX1 c.337T>C (p.Y113H) variant, whichleads to altered enzyme activity, in pancreatic diseases. METHODS: We genotyped...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
